​

Funding Round

Series D - Biotheus

Series D - Biotheus

Investment Firm

Overview

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.

Announced Date

Mar 02, 2021

Funding Type

Series D

Highlights

Location

Asia

Social

Investor Lead

General Atlantic

General Atlantic

General Atlantic is a early_stage_venture and late_stage_venture and private_equity firm.

IDG Capital

IDG Capital

IDG Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

7

Investor Name
Participant InvestorCowin Capital
Participant InvestorHighlight Capital
Participant InvestorKUNLUN
Participant InvestorIDG Capital
Participant InvestorGeneral Atlantic

Round Details and Background

Biotheus raised $100000000 on 2021-03-02 in Series D

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 30, 2018
Series A - Biotheus
2-25.8M
Jun 26, 2019
Seed Round - Biotheus
2-14.5M
Jun 29, 2020
Series C - Biotheus
2-5.0M
Mar 02, 2021
Series D - Biotheus
10-100.0M

Recent Activity

There is no recent news or activity for this profile.